XENO Stock Analysis
XE
Uncovered
Xeno Transplants Corp is uncovered by Eyestock quantitative analysis.
Xeno Transplants Corporation, formerly Icon Development, Inc., is a bio-technology research and development company that holds an exclusive commercial license from Massachusetts General Hospital derived from over 15 years of development in the field of xenotransplantation by Novartis Pharmaceuticals and its associated research entities. The Company intends to develop therapeutic applications of organs and cells derived from genetically engineered pigs as a transplant alternative to limited human donor sources.
View Section: Eyestock Rating